Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Absci (ABSI) Research & Development: 2020-2025

Historic Research & Development for Absci (ABSI) over the last 6 years, with Sep 2025 value amounting to $19.2 million.

  • Absci's Research & Development rose 7.03% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.4 million, marking a year-over-year increase of 28.91%. This contributed to the annual value of $63.9 million for FY2024, which is 32.85% up from last year.
  • Absci's Research & Development amounted to $19.2 million in Q3 2025, which was down 5.91% from $20.5 million recorded in Q2 2025.
  • Absci's 5-year Research & Development high stood at $20.5 million for Q2 2025, and its period low was $7.0 million during Q1 2021.
  • Over the past 3 years, Absci's median Research & Development value was $15.3 million (recorded in 2024), while the average stood at $15.3 million.
  • As far as peak fluctuations go, Absci's Research & Development skyrocketed by 478.92% in 2021, and later dropped by 28.96% in 2023.
  • Absci's Research & Development (Quarterly) stood at $15.8 million in 2021, then decreased by 28.23% to $11.3 million in 2022, then rose by 8.43% to $12.3 million in 2023, then surged by 49.78% to $18.4 million in 2024, then grew by 7.03% to $19.2 million in 2025.
  • Its last three reported values are $19.2 million in Q3 2025, $20.5 million for Q2 2025, and $16.4 million during Q1 2025.